Phẫu thuật điều trị u máu gan kích thước lớn: Kinh nghiệm tại một trung tâm với 43 trường hợp

Abstract

Objective: To evaluate the outcome of surgical treatment for giant hepatic hemangioma (HH). Subject and method: This was a retrospective study of the cases who underwent surgery for giant hepatic hemangioma from June 2015 to January 2021 in 108 Military Central Hospital. Result: Elective surgery was performed for 43 patients who had giant hepatic hemangioma. The median diameter of resected hepatic hemangioma was 8.99 ± 7.88cm (5 - 28cm). Indication of surgery: Pain (81.4%), rapid growth (9.3%), suspicious for malignancy (9.3%). Enucleation was performed for 25 (58.1%) patients and anatomical resection was required in 18 (41.9%) patients. The median blood transfusion was 213.95 ± 214.18ml, the need of blood transfusion was required in 2 (4.65%) patients, and the median operation time was 151.16 ± 50.61 min. Postoperative complications occurred in 8 (18.6%) patients, including: bile leakage 2 (4.65%) patients, bleeding 1 (2.32%) patient, pleural effusion 4 (9.3%) patients, wound infection 1 (2.32%) patient. The average length of hospital stay was 9.02 ± 1.82 days. Conclusion: Giant hemangioma can be treated surgically with low incidence of morbidity and mortality. In left lobe hepatic hemangioma, hepatic hemangioma located deeper in posterior hepatic segments and in multiple hepatic hemangioma, hepatic resection is preferred.